Range Cancer Therapeutics ETF (CNCR) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free CNCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePromising Clinical Trials and Strong Financial Position Support Buy Rating for Context Therapeuticsmarkets.businessinsider.com - May 10 at 1:38 AMRing Therapeutics Presents New Data on Anellogy™ Platform at the 27th Annual American Society of Gene & Cell Therapy Conferencemarkets.businessinsider.com - May 7 at 6:44 AMBuy Rating for CytomX Therapeutics on Promising CX-904 Probody Therapy Prospectsmarkets.businessinsider.com - May 6 at 12:31 AMLarge-scale study explores genetic link between colorectal cancer and meat intakemsn.com - March 15 at 4:42 PMMicrobix Unveils Test Controls for Head and Neck Cancermarkets.businessinsider.com - March 11 at 7:30 AMThe Zacks Analyst Blog Highlights CRPT, CNCR, WISE, AIRR and PKBnasdaq.com - March 3 at 1:49 AMFDA approval of cancer treatment provides new weapon against tumorsmsn.com - February 22 at 1:11 PMA watershed moment for cancer therapies has arrivedmsn.com - February 21 at 7:46 PMETF S.S.-LONCAR CAN.I.ETF (E18B.BE)nz.finance.yahoo.com - February 5 at 9:11 PMWhy Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?msn.com - January 24 at 3:33 PMTScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progressmarkets.businessinsider.com - January 4 at 7:31 AMLocalized genetic mutations may serve as biomarker for wide range of cancersmsn.com - December 21 at 1:53 PM12 Most Promising Cancer Stocks According to Analystsuk.finance.yahoo.com - December 18 at 3:35 PMKorro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Millionmarkets.businessinsider.com - November 3 at 3:31 PMGenerate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AIbusinesswire.com - November 1 at 7:27 AMGPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100markets.businessinsider.com - October 26 at 8:49 AMEXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATIONfinance.yahoo.com - October 23 at 9:02 AMFDA Raises Concerns About Cell Therapeutics' Cancer Drugthestreet.com - October 20 at 8:36 AMKura Oncology's Head & Neck Cancer Candidate Shows Meaningful Antitumor Activity In Pretreated Patientsmarkets.businessinsider.com - October 18 at 2:17 PMTriple Negative Breast Cancer Market Size in the 7MM is expected to change during the study period 2019-2032, estimates DelveInsightbenzinga.com - October 4 at 9:04 PMNektar in collaboration to evaluate non-small cell lung cancer candidateseekingalpha.com - September 27 at 3:17 PMMerck Gets CHMP Backing for Keytruda as Non-Small Cell Lung Cancer Adjuvant >MRKmarketwatch.com - September 15 at 10:04 AMWhy Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?benzinga.com - September 11 at 2:54 PMWhy Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?markets.businessinsider.com - September 7 at 3:24 PMETF Series Solutions Trust - Range Cancer Therapeutics ETFmoney.usnews.com - September 6 at 7:22 PMCanaccord Genuity Maintains BioXcel Therapeutics (BTAI) Buy Recommendationnasdaq.com - August 16 at 7:31 AMBest & Worst Sector ETFs of First-Half 2023uk.style.yahoo.com - June 28 at 12:32 PMCNCR - Loncar Cancer Immunotherapy ETFfinance.yahoo.com - May 25 at 5:53 PMNew Computational Tool Identifies Novel Targets for Cancer Immunotherapymarkets.businessinsider.com - May 20 at 12:27 AMWhere to Be in ETFs for Rising Biotech M&Anasdaq.com - May 11 at 12:54 PMLoncar Cancer Immunotherapy ETF (NASDAQ:CNCR), Quotes and News Summarybenzinga.com - April 14 at 11:16 PMCNCR Loncar Cancer Immunotherapy ETFseekingalpha.com - March 24 at 8:00 AMSurgery First for Colon Cancer? Not So Fast, According to New Study in JNCCNmarkets.businessinsider.com - January 11 at 6:42 PMATP and NYU Langone Health Launch Aethon Therapeutics to Eradicate Drug-Resistant Cancer Cellsmarkets.businessinsider.com - January 9 at 8:03 AMHow to invest, profit and give back using ETFstheglobeandmail.com - December 5 at 8:29 AMETFs to Watch: Crypto, earnings reports, Treasury yields and moreseekingalpha.com - November 14 at 12:25 AMWisdomTree Exec on Spot Bitcoin ETF Rejection: No Silver Bullet to Addressmsn.com - October 16 at 4:05 PMHotSpot Therapeutics to Present Preclinical Data from CBL-B Program at 2022 Society for Immunotherapy of Cancer Annual Meetingmarkets.businessinsider.com - October 7 at 5:14 PMLung cancer pill outperforms chemotherapy in clinical trialsfinance.yahoo.com - September 13 at 1:23 PMMount Sinai Researchers Report Encouraging Immunotherapy Option for Relapsed Myeloma Patientsbenzinga.com - September 1 at 4:22 PMNational Pediatric Cancer Foundation Leads the Fight Against Childhood Cancerfinance.yahoo.com - September 1 at 9:56 AMRoche Reports CE Label Expansion Of VENTANA PD-L1 Assay In Non-small Cell Lung Cancermarkets.businessinsider.com - August 24 at 2:21 AMThe Zacks Analyst Blog Highlights BBC, CNCR XBI, BBP, and SBIOfinance.yahoo.com - July 11 at 9:14 AMPharma & Biotech ETFs at One-Month High: Here's Whyfinance.yahoo.com - July 8 at 5:37 PMMerck in talks to buy cancer biotech Seagen: reportfinance.yahoo.com - July 7 at 3:17 AMXNK broadens its pipeline with bladder cancer studybenzinga.com - June 28 at 6:11 PMDGAP-News: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platformmarkets.businessinsider.com - June 8 at 4:47 PMImmunotherapy treats recurring melanomafinance.yahoo.com - June 7 at 6:22 PMExercise Amplifies Immune Attack on Pancreatic Cancerfinance.yahoo.com - June 2 at 3:49 PMTC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthroughbenzinga.com - June 2 at 3:49 PM Get Range Cancer Therapeutics ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here CNCR Media Mentions By Week CNCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNCR News Sentiment▼0.000.96▲Average News Sentiment CNCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNCR Articles This Week▼40▲CNCR Articles Average Week Get Range Cancer Therapeutics ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CNCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IBBQ News Today BTEC News Today BIB News Today PSCH News Today BBH News Today PPH News Today IBB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNCR) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
